Home > Healthcare > Medical Devices > Diagnostic Devices > Zika Virus Testing Market

Zika Virus Testing Market Trends

  • Report ID: GMI5926
  • Published Date: Jun 2023
  • Report Format: PDF

Zika Virus Testing Market Trends

The zika virus infection has emerged as a significant global health concern due to its potential to cause severe birth defects and neurological complications. For instance, according to the World Health Organization (WHO), zika virus infection declared as endemic in Southeast Asia and Africa region. Thus, increasing prevalence of zika virus infection will increase demand for robust testing methods to detect and manage the disease effectively leading to surge in the demand for zika virus testing.
 

In addition, as zika virus infection becomes more prevalent, healthcare providers are integrating zika virus testing into routine care. This includes incorporating testing protocols into prenatal care, ensuring timely screening of pregnant women, and implementing surveillance programs to monitor the spread of the virus. Moreover, growing awareness campaigns to educate population, healthcare professionals and pregnant women about zika virus transmission, prevention, and the importance of testing will boost industry.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for zika virus testing was valued at over USD 174 million in 2022 and will reach more than USD 366 million by 2032, owing to substantial infection awareness, along with growing preference for point of care testing for zika virus for precise detection and effective patient management.

The molecular tests segment will witness CAGR of 7.8% by 2032, backed by the ontinuous technological advancements in molecular diagnostics.

The U.S. zika virus testing market accounted for over USD 40 million in 2022 and is anticipated to witness substantial growth through 2032, on account of growing awareness and concern regarding the impact of zika virus on public health.

Abbott Laboratories, Altona Diagnostics GmbH, ChemBio Diagnostics, Inc., ELITechGroup, F. Hoffmann-La Roche Ltd., LGC Limited (SeraCare Life Sciences), Co-Diagnostics, Inc., Mediven (Medical Innovation Ventures), Biocan Diagnostics, Inc. and Euroimmun among others.

Zika Virus Testing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 298
  • Countries covered: 25
  • Pages: 165
 Download Free Sample